Uterine cancer, i.e. endometrial cancer
Endometrial cancer, i.e. uterine cancer, is a cancer that arises from a malignant change within cells in the endometrium (the lining of the uterus).
The risk of endometrial cancer is increased, among other things, by older age, diabetes, changes in the balance of hormones and a thickening of the uterus. Uterine cancer is the most common gynaecological cancer and it is more commonly found in women of 60–70 years of age. It is further expected to increase as the average lifetime and obesity increase.
Symptoms of endometrial cancer
A first symptom of endometrial cancer is often vaginal bleeding similar to menstruation occurring after menopause, which can always be considered a significant reason for examination. Before menopause, a sign of endometrial cancer may be heavy vaginal bleeding or bleeding between periods.
Diagnosis of endometrial cancer
If endometrial cancer is discovered at an early stage and it has not had time to spread outside the uterus, the probability of a cure is high. Fortunately, the diagnosis is facilitated by clear symptoms and a simple examination method. In the examination, a gynaecologist takes a tissue sample of the lining of the uterus, i.e. a so-called suction sample, using a flexible and narrow plastic tube. Magnetic resonance imaging as well as a CT scan may be used as supplementing methods. At Docrates, all these diagnostic tools are conveniently provided under one roof which means that they can be provided over just one visit.
Comprehensive treatment of endometrial cancer at Docrates Cancer Center
Uterine cancer is primarily treated by surgery where the uterus and ovaries and, if necessary, the lymph nodes in the uterus area are removed. The follow-up treatment is determined according to the spread of cancer. Endometrial cancer that has spread to the muscle layer often requires radiotherapy and chemotherapy.
We treat our clients according to the latest international and domestic treatment recommendations. Our multiprofessional team of specialists provides each and every patient with individually tailored and comprehensive diagnostics and treatment as well as possibility of the newest medicines. Our team is made of numerous specialist doctors, including oncologists, radiotherapy doctors, gynaecologists, surgeons, isotope doctors, radiologists, a pathologist, and also nurses who are all experienced cancer treatment experts. Our clients have the opportunity to participate in new drug treatments and clinical trials. We also offer complementary services, such as physiotherapy and sexual counselling.
If you suspect cancer or have been diagnosed with cancer, you can make an appointment with a Docrates Cancer Center specialist without delay and referral. Our friendly personnel understand the fears and concerns related to cancer and can give you support from the first contact onwards.
Breakthroughs in the treatment of metastatic breast cancer
New forms of drug therapy can almost double the life expectancy of patients with advanced breast cancer and allow treatment...Read more
Docrates Cancer Center has appointed Anna-Sofia Malmi as Marketing and Communications Director
Anna-Sofia Malmi, M.Sc (Education), has been appointed as Marketing and Communications Director at Docrates Cancer Center and a member of...Read more
Accurate information on aggressiveness and tumor staging form the basis for prostate cancer treatment
In western countries, prostate cancer is the most common cancer type in men. In its early stages, it is often...Read more
Should low-risk prostate cancer be left to active monitoring?
Active treatment vs. monitoring of localised low-risk prostate cancer has long been a contested topic. According to the results of...Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.